GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (OSTO:IMP A SDB) » Definitions » Debt-to-EBITDA

Implantica AG (OSTO:IMP A SDB) Debt-to-EBITDA : 0.00 (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Implantica AG Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Implantica AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was kr0.00 Mil. Implantica AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was kr0.00 Mil. Implantica AG's annualized EBITDA for the quarter that ended in . 20 was kr0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Implantica AG's Debt-to-EBITDA or its related term are showing as below:

OSTO:IMP A SDB's Debt-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.445
* Ranked among companies with meaningful Debt-to-EBITDA only.

Implantica AG Debt-to-EBITDA Historical Data

The historical data trend for Implantica AG's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Implantica AG Debt-to-EBITDA Chart

Implantica AG Annual Data
Trend
Debt-to-EBITDA

Implantica AG Semi-Annual Data
Debt-to-EBITDA

Competitive Comparison of Implantica AG's Debt-to-EBITDA

For the Medical Devices subindustry, Implantica AG's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Implantica AG's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Implantica AG's Debt-to-EBITDA falls into.


;
;

Implantica AG Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Implantica AG's Debt-to-EBITDA for the fiscal year that ended in . 20 is calculated as

Implantica AG's annualized Debt-to-EBITDA for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (. 20) EBITDA data.


Implantica AG  (OSTO:IMP A SDB) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Implantica AG Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Implantica AG's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Implantica AG Business Description

Comparable Companies
Traded in Other Exchanges
Address
Aeulestrasse 45, Vaduz, LIE, 9490
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. Its lead product, RefluxStop, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results.

Implantica AG Headlines

No Headlines